San Diego Biotechnology Connection


Not Yet A Member? Register Now. | Forgot Password?
  • Twitter
  • Facebook
  • Google+
  • LinkedIn
  • YouTube
  • RSS
  • Home
  • Careers
    • Biotech Careers News
    • Searchable Lists of SD Biotech Jobs
    • The Career Coach
  • Biotechs A
    • Acadia Pharmaceuticals
    • Adamis Pharmaceuticals
    • Adventrx Pharmaceuticals
    • Affymetrix
    • Allylix Inc
    • Ambit Biosciences
    • Ambrx, Inc.
    • Amgen
    • Amylin Pharmaceuticals
    • Apricus Biosciences
    • Ardea Biosciences
    • Arena Pharmaceuticals
  • Biotechs B-D
    • BioSurplus
    • BrainCells Inc.
    • Bristol-Myers Squibb
    • Cadence Pharmaceuticals
    • Cardium Therapeutics
    • CareFusion
    • Ceregene Inc.
    • Colorescience
    • Cubist Pharmaceuticals
    • Dexcom
    • Digirad Corp
  • Biotechs E-H
    • Elevation Pharmaceuticals
    • Forest Laboratories
    • Gen-Probe
    • Genelux Corp
    • Genentech
    • Genocea Biosciences
    • Glaxo Smith Kline
    • Halozyme Therapeutics
    • Histogen
    • Hologic
  • Biotechs I-M
    • Illumina
    • Isis Pharmaceuticals
    • La Jolla Pharmaceutical
    • Life Technologies
    • Ligand Pharmaceuticals
    • Lpath
    • MediStem
    • Merck
    • Monsanto
  • Biotechs N-Q
    • NetDx
    • Novartis
    • Optimer Pharmaceuticals
    • Orexigen
    • Oxford Nanopore
    • Pacira Pharmaceuticals
    • Pfizer
    • Prometheus Laboratories
    • Quidel Corp
  • Biotechs R-S
    • Rempex Pharmaceuticals
    • Reset Therapeutics
    • ResMed
    • Reva Medical
    • Roche
    • Sangamo BioSciences
    • Sanofi Pasteur
    • Santarus
    • Santech
    • Sequenom
  • Biotechs T-Z
    • Tioga Pharmaceuticals
    • Trius Therapeutics
    • TrovaGene
    • Ventrix
    • Verenium Corp
    • ViaCyte
    • Vical Inc
    • Vivus Inc
    • Zacharon Pharmaceuticals
    • Zogenix
  • Login
  • Register
  • Subscribe
  • About
  • Academic Hubs
  • Biotech Jobs
  • Contact Us
  • Biotech Events in San Diego

The Scripps Research Institute

Human circadian clock, San Diego Biotechnology Connection

Circadian clock drugs coming to treat cancer, diabetes, other diseases

August 13, 2012 no comments
By Rex Graham Potential circadian clock drugs with relevance to a broad spectrum of diseases from cancer and diabetes to sleep disorders are the offshoots of discoveries reported this year that expla Read More
Cure for HIV, San Diego Biotechnology Connection

‘Cure for HIV’ in sight, scientists refine research targets

August 3, 2012 no comments
By Rex Graham Pfizer (PFE) has the only FDA-approved drug in a class called CCR5 antagonists, and a “cure for HIV” will most likely focus on CCR5, top scientists agree. If not Pfizer̵ Read More
Envelope protein of HIV-1, Journal of Virology, San Diego Biotechnology Connection

Vaccine against HIV goal of $77 million NIH grant to Scripps Research

July 11, 2012 no comments
By Mika Ono The Scripps Research Institute LA JOLLA, Calif. – July 11, 2012 – The Scripps Research Institute has been awarded a grant expected to total more than $77 million from the National Institu Read More
Jin-Quan Yu, TSRI, San Diego Biotechnology Connection

Synthetic drugs easier to make with new chemistry tools

June 27, 2012 no comments
Chemists at The Scripps Research Institute have invented a new way to add small organic molecules to larger ones in ways that can be applied to the modification of existing drugs to improve them or g Read More
Scripps Research Institute, San Diego Biotechnology Connection

Drug discovery tools at Scripps sought by Bristol-Myers Squibb

June 18, 2012 no comments
By Rex Graham A new five-year collaboration with Bristol-Myers Squibb (NYSE:BMY) announced June 15 by The Scripps Research Institute is one of the latest of “hundreds” of technology licensing deals b Read More
Michael Marletta and a microbial matrix, San Diego Biotechnology Connection

Microbes use slimy biofilm matrix to dodge our slo-mo bullets

April 26, 2012 no comments
By Rex Graham Scientists are making progress in understanding a nearly invisible but very real threat to human health, a slimy biofilm matrix that conjures the invisible force fields of the classic s Read More
The Two Peters: Peter S. Kim and Peter G. Schultz, San Diego Biotechnology Connection

Drug discovery scientists ‘two Peters’ in $90 million Merck institute

March 18, 2012 no comments
By Rex Graham “The two Peters” is a suddenly popular term among San Diego drug-discovery scientists excited about the formation of a new drug-discovery research institute in La Jolla. This disruptive Read More
Senomyx and Life Sciences Summer Institute, San Diego Biotechnology Connection

Paid life sciences internships, free biotech job-training in San Diego

February 28, 2012 no comments
San Diego County high school students with good grades and a passion for the life sciences have until March 31 to apply for an unforgettable, paid eight-week life sciences internships this summer in Read More
Chronic pain metabolite, San Diego Biotechnology Connection

Targeted drug treatment closer for sufferers of chronic pain

January 27, 2012 no comments
By Rex Graham Millions of sufferers of chronic pain worldwide have neuropathic pain, a type of continuous or episodic burning, coldness, pins-and-needles or other sharply painful sensations triggered Read More
Anti-oxidants in food, San Diego Biotechnology

Routine oxidation in cells casts doubt on anti-oxidant benefits

December 13, 2011 no comments
By Rex Graham Scientists at The Scripps Research Institute question assumed anti-oxidant benefits after they identified the importance of a novel protein-regulating mechanism that can employ hydrogen Read More

Stock Daily Change

ADMP0.695  chart-0.005
AEMD0.096  chart-0.0001
AHRO0.70  chart-0.03
AIMM0.0035  chart0.00
AMGN105.57  chart+1.04
ANX0.733  chart0.00
APRI2.62  chart-0.68
ARNA8.00  chart+0.08
ATEC1.90  chart-0.01
AVNR3.29  chart+0.04
AVTO0.005  chart0.00
AXMP0.015  chart0.00
AXRX0.16  chart0.00
CADX6.90  chart+0.20
CELG124.339  chart+0.899
CORX0.045  chart0.00
CXM0.0955  chart+0.0005
CYTX2.49  chart-0.02
CYTR2.31  chart0.00
DRAD2.40  chart-0.03
DXCM19.9999  chart-0.3601
ENTB0.0018  chart0.00
FOLD3.41  chart-0.05
HALO7.4732  chart+0.3032
HRBR0.19  chart+0.0299
IAGXQ0.14  chart0.00
ILMN71.065  chart+0.375
IMBI0.028  chart0.00
ISCO0.271  chart-0.024
ISIS20.81  chart+0.42
IVRO0.0245  chart+0.0075
LGND28.13  chart+0.75
LIFE73.99  chart-0.11
LJPC0.0725  chart-0.0045
LPTN4.93  chart+0.06
MCK117.13  chart-0.42
MEDS1.10  chart0.00
MEIP8.34  chart-0.08
MLPH0.018  chart0.00
MNKD6.715  chart+0.485
MNOV3.03  chart-0.15
MRIC1.20  chart+0.05
NAII4.59  chart-0.09
NBIX12.31  chart+0.30
NRDCQ0.0001  chart0.00
NUXP0.0016  chart0.00
ONCS0.314  chart+0.004
OPTR14.31  chart-0.07
OREX6.28  chart+0.09
PCRX29.57  chart+0.49
PFE29.065  chart-0.235
QDEL21.66  chart-0.28
RHHBY64.95  chart-0.70
RMD49.90  chart+0.18
SNTS22.49  chart+0.21
SQNM4.01  chart+0.10
TSRX7.79  chart+0.19
VOLC16.81  chart+0.14
VRX74.56  chart-0.26
VRNM2.1401  chart-0.0499
VVUS14.47  chart+0.95
ZGNX1.48  chart-0.03
2013-05-23 10:32

Featured Videos

Registered User Login

You are not currently logged in.






» Register
» Lost your Password?

Search This Site

Biotech Events in San Diego

May  2013
MTWTFSS
 12345
6789101112
13141516171819
20212223
Events on May 23, 2013
  • Studies Toward the Synthesis of Antitumor Natural Products
    Starts: 4:00 pm
    Ends: May 23, 2013 - 5:00 pm
    Location: Scripps Research Inst. - Green Hospital Building, Valerie Timken Amphitheater
    Description: Distinguished Lecture Series
    Speaker: John A. Porco, Ph.D., Professor, Department of Chemistry, Boston University
    Read More: <a href="http://pubs.rsc.org/en/content/articlelanding/2013/np/c3np20122h">link</a&gt;
    More details...
242526
2728293031 

@SDBiotech

  • Trius Therapeutics: New, Positive Dimension For Investment Outlook http://t.co/rcVXC57kkN $CBST $TEVA $TSRX
    9 days ago
    Retweet
  • @ilus_art Gorgeous way to celebrate art, biology and cells.
    18 days ago
    Retweet
  • Trius Therapeutics releases persuasive safety study of potent new antibiotic against MRSA #superbug. http://t.co/uRBiPHj14U
    24 days ago
    Retweet
  • Halozyme initiates Phase 2 trial of drug to treat stage 4 pancreatic cancer. http://t.co/U9cjxGbtIL
    30 days ago
    Retweet
  • Illumina’s stronger than expected revenue up 21% sends shares up 13%. http://t.co/qviU0MYLQ3
    30 days ago
    Retweet
  • Trius presenting clinical-trial results Apr. 27 http://t.co/MCFeBYi57w on tedizolid, a potent MRSA antibiotic. http://t.co/myB421ZD2n
    30 days ago
    Retweet
  • After Thermo Fisher Scientific buys Life Technologies, sequencing leader Illumina may finally sell. http://t.co/F92ndBP0z2
    38 days ago
    Retweet
  • http://t.co/y8xbsAQ4q8
    62 days ago
    Retweet
  • FDA reviewing diabetes drugs causing pancreas precancers. Affected: Lilly, Merck, Novo Nordisk, Bristol-Myers. http://t.co/2dPyRAYLsc
    69 days ago
    Retweet

Find us on Facebook

San Diego Biotechnology Connection

  • The share price of Trius Therapeutics (TSRX) has rebounded almost fully from its 10 percent dip in the New Year that was triggered by its public offering of 7 million shares; however, uncertainty about the company’s lead investigational drug is a lingering February hangover. Small investors face a dilemma: should they dump their diluted shares, double down? Our story explains why we recommend doubling down: http://sandiegobiotechnology.com/topics/5733/trius-dump-or-double-down-on-maker-of-mrsa-antibiotic/
    101 days ago
  • A Glaxo Smith Kline genital herpes vaccine recently flopped in a large clinical trial, but “next generation” genital herpes vaccines by Genocea Biosciences, Agenus, Inc., and San Diego-based Vical, Inc., offer new hope. http://sandiegobiotechnology.com/topics/5600/glaxo-genital-herpes-vaccine-flops-but-genocea-a-buy-in-vaccine-space/
    160 days ago
  • The Dow was off 1.82 percent, down 243.36 points to 13,102.53 at the close of trading Oct. 23 amid disappointing earnings reports. But 11 publicly traded San Diego biotechs gained for the day. https://sandiegobiotechnology.com/topics/5443/eleven-san-diego-biotech-stocks-rise-amid-tuesday-plunge-in-dow/
    211 days ago
  • Millions of infertile women will soon get the biggest baby boost in a generation from preimplantation genetic diagnosis (PGD), which identifies their healthiest embryos at in vitro fertilization (IVF) clinics. These blastocysts, embryos with 50-150 cells, are at a very favorable stage for implantation and pregnancy. The inner cell mass will give rise to the actual cells of the fetus. The other cells that surround and protect the inner cell mass give rise to the fetal part of the placenta. Photo: Robert Shabanowitz, Gesinger Medical Center
    213 days ago
  • It’s more than a 5-hour energy jolt. Cardium Therapeutics’ purchase of To Go Brands and its nationwide marketing network will give the San Diego biotech company a permanent sales boost for its own nutritional supplements -- and a larger piece of the $30 billion supplements market. https://sandiegobiotechnology.com/topics/5393/cardium-boosts-energy-supplement-sales-with-national-marketing-muscle/
    233 days ago

Recent Posts

Thermo Fisher acquiring Life Technologies — Illumina ...
Thermo Fisher acquiring Life Technologies -- Illumina merger next?

By Rex Graham Thermo Fisher Scientific’s (TMO) decision to acquire Life Technologies for $13.6 billion will create a sequencing and diagnostics juggernaut that will position Fisher to become a dominant player in the emerging field of personalized med...

MRSA, University of Wisconsin, San Diego Biotechnology Connection
Trius: dump or double down on maker of MRSA antibiotic?

By Rex Graham The share price of Trius Therapeutics (TSRX) has rebounded from its 10 percent dip in the New Year that was triggered by its public offering of 7 million shares; however, uncertainty about the company’s lead investigational drug i...

Trius: dump or double down on maker of MRSA antibiotic?
Glaxo genital herpes vaccine flops but Agenus a buy in vacci...
Genital herpes vaccine, NIH, San Diego Biotechnology ConnectionChip Clark, CEO, Genocea Biosciences (San Diego Biotechnology Connection)David_Knipe, Harvard Medical School.credit: Liza Green
More insurers, ObamaCare to cover obesity drugs made by Aren...
Go4Life, NIH, San Diego Biotechnology ConnectionMichael Kaplan, The Center for Medical Weight Loss, San Diego Biotechnology ConnectionUmesh Masharani, UCSF, San Diego Biotechnology Connection
Sangamo applying ‘cure for HIV’ technology to he...
Timothy Brown. Photo: Eva KolenkoHIV-1 infection of T cells, Zenda WoodmanAdam Bogdanove, Iowa State University, San Diego Biotechnology Connection

Most Popular Posts

1

California biotechs encounter FDA blockade on diet...

Jan 10, 2012 2
2

Glaxo genital herpes vaccine flops but Agenus a bu...

Dec 14, 2012 1
3

Thermo Fisher acquiring Life Technologies — ...

Apr 26, 2013 0
4

Brown University study: Sequenom Down syndrome tes...

May 21, 2012 0
5

Vical genital herpes vaccine protects animals; hum...

May 23, 2012 0

On Flicker

    Members Area

    You are not currently logged in.






    » Register
    » Lost your Password?

    Contact

    ©2013 San Diego Biotechnology Connection